secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 76336 grounded facts newest September 2, 2026, 7:58 AM ET RSS · JSON

Showing 5851–5900 of 76336

Departed

Ho Seok (Roberto) Kim

Chief Financial Officer
CORETEC GROUP INC.
Effective
2024-11-18
Successor
Antti Uusiheimala
Filed
November 20, 2024, 6:59 PM ET
Ho Seok (Roberto) Kim resigned as Chief Financial Officer of the Company, which resignation was not as a result of any disagreements with the Company or its management.
Departed

Kimberly Johnson

Senior Vice President, Controller and Principal Accounting Officer
HMN · HORACE MANN EDUCATORS CORP /DE/
Effective
2025-01-03
Successor
Ryan Greenier
Filed
November 20, 2024, 6:59 PM ET
Kimberly Johnson, the Company's current Senior Vice President, Controller and Principal Accounting Officer, announced her plans to retire from the Company effective January 3, 2025.
Departed

Alfredo Papadakis

sole Director and officer
VGTel, Inc.
Effective
2024-10-22
Successor
Ken Williams
Filed
November 20, 2024, 6:59 PM ET
Our Company’s current sole Director and officer Alfredo Papadakis has resigned, and Ken Williams has been appointed as sole director and President, Secretary and CFO.
Departed

Karen Walker

Director
LLY · ELI LILLY & Co
Effective
2024-12-31
Filed
November 19, 2024, 6:59 PM ET
Karen Walker notified the Board of her resignation from the Board effective December 31, 2024.
Departed

Brian J. Lipke

Director
MOG-A · MOOG INC.
Filed
November 19, 2024, 6:59 PM ET
Brian J. Lipke informed the Board of Directors (the “Board”) of Moog Inc. (the “Company”) that he intends to retire from the Board immediately prior to the Company’s 2025 annual meeting of shareholders
Departed

Stacy Loretz-Congdon

Director
FARM · FARMER BROTHERS CO
Filed
November 19, 2024, 6:59 PM ET
On November 13, 2024, Stacy Loretz-Congdon communicated to the Board of Directors (the “Board”) of Farmer Bros. Co., a Delaware corporation (the “Company”), her decision not to stand for reelection as a member of the Board at the Company’s 2025 Annual Meeting of Stockholders.
Departed

Rajneesh Vig

Director
BlackRock Direct Lending Corp.
Effective
2024-11-15
Filed
November 19, 2024, 6:59 PM ET
On November 15, 2024, Mr. Vig informed the Company that his resignation as Director of the Company will be effective as of the close of business on November 15, 2024.
Departed

Rajneesh Vig

Trustee
BlackRock Private Credit Fund
Effective
2024-11-15
Filed
November 19, 2024, 6:59 PM ET
On November 15, 2024, Mr. Vig informed the Company that his resignation as a Trustee of the Company will be effective as of the close of business on November 15, 2024.
Departed

David I. Chemerow

director
RiceBran Technologies
Effective
2024-11-15
Filed
November 19, 2024, 6:59 PM ET
On November 15, 2024, David I. Chemerow, Brent D. Rosenthal and Georgina Russell notified the Company’s Board of Directors of their individual decisions to resign as directors of the Company, effective immediately.
Departed

Brent D. Rosenthal

director
RiceBran Technologies
Effective
2024-11-15
Filed
November 19, 2024, 6:59 PM ET
On November 15, 2024, David I. Chemerow, Brent D. Rosenthal and Georgina Russell notified the Company’s Board of Directors of their individual decisions to resign as directors of the Company, effective immediately.
Departed

Georgina Russell

director
RiceBran Technologies
Effective
2024-11-15
Filed
November 19, 2024, 6:59 PM ET
On November 15, 2024, David I. Chemerow, Brent D. Rosenthal and Georgina Russell notified the Company’s Board of Directors of their individual decisions to resign as directors of the Company, effective immediately.
Departed

Andrew Call

Director
ALPINE 4 HOLDINGS, INC.
Effective
2024-11-14
Filed
November 19, 2024, 6:59 PM ET
On November 14, 2024, Andrew Call submitted his resignation as a member of the Board of Directors (the “Board”), as well as from his position as Chair of the Audit Committee of the Board, effective immediately.
Departed

Christopher A. Wright

Chief Executive Officer
LBRT · Liberty Energy Inc.
Successor
Ron Gusek
Filed
November 19, 2024, 6:59 PM ET
Accordingly, on that date, Mr. Wright resigned from his positions as Chairman of the Board, Director and Chief Executive Officer of the Company, effective upon and subject to the Confirmation Condition.
Departed

Christopher A. Wright

Chairman of the Board and Director
LBRT · Liberty Energy Inc.
Successor
William Kimble
Filed
November 19, 2024, 6:59 PM ET
Accordingly, on that date, Mr. Wright resigned from his positions as Chairman of the Board, Director and Chief Executive Officer of the Company, effective upon and subject to the Confirmation Condition.
Departed

Jamie Siminoff

Chief Strategy Officer
LTCH · Latch, Inc.
Effective
2024-12-31
Filed
November 19, 2024, 6:59 PM ET
Jamie Siminoff, the Company’s Chief Strategy Officer, mutually agreed that Mr. Siminoff would step down as the Company’s Chief Strategy Officer on December 31, 2024 (the “Siminoff Separation Date”).
Departed

Tao Levy

Executive Vice President, Business Development
MASI · MASIMO CORP
Effective
2024-11-13
Filed
November 18, 2024, 6:59 PM ET
On November 13, 2024, in connection with its strategic shift to refocus on its core healthcare business, Masimo Corporation (the “ Company ”) terminated the employment of Tao Levy, the Company’s Executive Vice President, Business Development.
Departed

John C. Lee, Jr.

President and Chief Executive Officer
OLD DOMINION ELECTRIC COOPERATIVE
Effective
2025-02-01
Successor
Christopher F. Cosby
Filed
November 18, 2024, 6:59 PM ET
On November 12, 2024, John C. Lee, Jr. gave notice of his resignation as President and Chief Executive Officer ("CEO") of Old Dominion Electric Cooperative ("ODEC"), effective February 1, 2025.
Departed

Ann Taylor

Member of the Board of Directors
TERN · Terns Pharmaceuticals, Inc.
Effective
2024-11-18
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, Ann Taylor notified Terns Pharmaceuticals, Inc. (the “Company”) of her resignation from the Company’s Board of Directors (the “Board”), effective as of November 18, 2024.
Departed

Steve Richards

Chief Executive Officer
SHIM · Shimmick Corp
Effective
2024-12-02
Successor
Ural Yal
Filed
November 18, 2024, 6:59 PM ET
On November 12, 2024, Steve Richards, the Company’s Chief Executive Officer (“CEO”), announced his retirement as Chief Executive Officer of the Company, effective December 2, 2024.
Departed

Glen Leibowitz

Chief Financial Officer
BTM · Bitcoin Depot Inc.
Effective
2024-11-15
Successor
Scott Buchanan
Filed
November 18, 2024, 6:59 PM ET
Glen Leibowitz has resigned from his role as Chief Financial Officer (“CFO”) of the Company, effective November 15, 2024, for personal reasons.
Departed

Francisco J. Coll

Director
LEGH · Legacy Housing Corp
Successor
Skyler M. Howton
Filed
November 18, 2024, 6:59 PM ET
created by the resignation of Francisco J. Coll.
Departed

Gregory M. Share

Director
RWAY · Runway Growth Finance Corp.
Effective
2024-11-15
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, Gregory M. Share informed the Board of Directors (the “Board”) of Runway Growth Finance Corp., a Maryland corporation (the “Company”), of his intent to resign as a director of the Company.
Departed

Robert V. Deere

Chief Administrative Officer
GEL · GENESIS ENERGY LP
Effective
2024-12-31
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, Genesis Energy L.P. (the “Company”) announced that Robert V. Deere, the Company’s Chief Administrative Officer, intends to retire from his position at the Company effective December 31, 2024.
Departed

Timothy Tyson

Director
Syros Pharmaceuticals, Inc.
Effective
2024-11-15
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
Departed

David Roth

Chief Medical Officer
Syros Pharmaceuticals, Inc.
Effective
2024-11-22
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, in connection with the reduction in workforce, the Company notified each of Conley Chee, the Company’s President and Chief Executive Officer, Jason Haas, the Company’s Chief Financial Officer, and Dr. David Roth, the Company’s Chief Medical Officer, that the employment of such officers with the Company will terminate without cause, effective as of November 22, 2024.
Departed

S. Gail Eckhardt

Director
Syros Pharmaceuticals, Inc.
Effective
2024-11-15
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
Departed

Conley Chee

Director
Syros Pharmaceuticals, Inc.
Effective
2024-11-22
Filed
November 18, 2024, 6:59 PM ET
In addition, Mr. Chee resigned from the Board of Directors and all committees or subcommittees thereof, effective upon his termination of employment on November 22, 2024.
Departed

Deborah Dunsire

Director
Syros Pharmaceuticals, Inc.
Effective
2024-11-15
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
Departed

Conley Chee

President and Chief Executive Officer
Syros Pharmaceuticals, Inc.
Effective
2024-11-22
Successor
Gerald Quirk
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, in connection with the reduction in workforce, the Company notified each of Conley Chee, the Company’s President and Chief Executive Officer, Jason Haas, the Company’s Chief Financial Officer, and Dr. David Roth, the Company’s Chief Medical Officer, that the employment of such officers with the Company will terminate without cause, effective as of November 22, 2024.
Departed

Srinivas Akkaraju

Director
Syros Pharmaceuticals, Inc.
Effective
2024-11-15
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
Departed

Andrew M. Oh

Director
Syros Pharmaceuticals, Inc.
Effective
2024-11-12
Filed
November 18, 2024, 6:59 PM ET
On November 12, 2024, Andrew M. Oh notified the Board of Directors of the Company of his resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
Departed

Jason Haas

Chief Financial Officer
Syros Pharmaceuticals, Inc.
Effective
2024-11-22
Successor
Gerald Quirk
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, in connection with the reduction in workforce, the Company notified each of Conley Chee, the Company’s President and Chief Executive Officer, Jason Haas, the Company’s Chief Financial Officer, and Dr. David Roth, the Company’s Chief Medical Officer, that the employment of such officers with the Company will terminate without cause, effective as of November 22, 2024.
Departed

Richard Young

Director
Syros Pharmaceuticals, Inc.
Effective
2024-11-15
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, Srinivas Akkaraju, M.D., Ph.D., Deborah Dunsire, M.D., S. Gail Eckhardt, M.D., Timonthy Tyson, and Richard Young, Ph.D., each notified the Board of Directors of such director’s resignation from the Board of Directors and all committees or subcommittees thereof, effective immediately.
Departed

Gregg A. Lowe

President and Chief Executive Officer
WOLF · WOLFSPEED, INC.
Effective
2024-11-18
Filed
November 18, 2024, 6:59 PM ET
On November 18, 2024, Wolfspeed, Inc. (the “Company”) announced the departure of its President and Chief Executive Officer, Gregg A. Lowe.
Departed

Gunther Plosch

Chief Financial Officer
WEN · Wendy's Co
Effective
2024-12-02
Successor
Kenneth Cook
Filed
November 18, 2024, 6:59 PM ET
Gunther Plosch will cease to be the Chief Financial Officer of the Company as of the Effective Date.
Departed

Nadir Ali

Sole Officer and Director
DMNIF · Damon Inc.
Effective
2024-11-13
Successor
Jay Giraud
Filed
November 18, 2024, 6:59 PM ET
Mr. Nadir Ali resigned as the sole officer and director of the Company.
Departed

Willy Verhaegen

director
MGAM · Mobile Global Esports, Inc.
Effective
2024-11-14
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, Willy Verhaegen, a director of Mobile Global Esports, Inc., resigned as a director for personal reasons.
Departed

Steven P. Rasche

Executive Vice President and Chief Financial Officer and Chief Accounting Officer
SR · SPIRE INC
Effective
2025-01-01
Successor
Adam W. Woodard
Filed
November 18, 2024, 6:59 PM ET
Steven P. Rasche, the Company’s current Executive Vice President and Chief Financial Officer and Chief Accounting Officer, has announced his retirement and will continue with the Company as Senior Adviser from January 1, 2025 until his retirement on April 1, 2025.
Departed

Steven P. Rasche

Executive Vice President and Chief Financial Officer
SR · SPIRE INC
Effective
2025-01-01
Successor
Adam W. Woodard
Filed
November 18, 2024, 6:59 PM ET
Steven P. Rasche, the Company’s current Executive Vice President and Chief Financial Officer and Chief Accounting Officer, has announced his retirement and will continue with the Company as Senior Adviser from January 1, 2025 until his retirement on April 1, 2025.
Departed

Steven P. Rasche

Chief Accounting Officer
SR · SPIRE INC
Effective
2025-01-01
Successor
Timothy W. Krick
Filed
November 18, 2024, 6:59 PM ET
Steven P. Rasche, the Company’s current Executive Vice President and Chief Financial Officer and Chief Accounting Officer, has announced his retirement and will continue with the Company as Senior Adviser from January 1, 2025 until his retirement on April 1, 2025.
Departed

Anthony S. Chan

Chief Financial Officer
SHARING SERVICES GLOBAL Corp
Effective
2024-11-14
Filed
November 18, 2024, 6:59 PM ET
On November 14, 2024, Anthony S. Chan ceased to be employed by Sharing Services Global Corporation (the “Company”) or any of its subsidiaries.
Departed

Mark DiSiena

Chief Financial Officer
UAVS · AgEagle Aerial Systems Inc.
Effective
2024-11-15
Successor
Adrienne Anderson
Filed
November 18, 2024, 6:59 PM ET
to replace Mark DiSiena who’s resignation from his position as Chief Financial Officer was effective November 15, 2024.
Departed

Michaela Griggs

Director
Guardion Health Sciences, Inc.
Effective
2024-11-14
Filed
November 18, 2024, 6:59 PM ET
Effective as of November 14, 2024, Michaela Griggs and Don Gagliano resigned from the Board of the Company
Departed

Don Gagliano

Director
Guardion Health Sciences, Inc.
Effective
2024-11-14
Filed
November 18, 2024, 6:59 PM ET
Effective as of November 14, 2024, Michaela Griggs and Don Gagliano resigned from the Board of the Company
Departed

Mark Castaneda

Director
Gold Flora Corp.
Effective
2024-11-30
Filed
November 18, 2024, 6:59 PM ET
On November 15, 2024, Mark Castaneda notified the Board of Directors (the “Board”) of Gold Flora Corporation (the “Company”) that he will resign as a member of the Board and its committees, effective as of November 30, 2024.
Departed

Gregory S. Lovins

Senior Vice President and Chief Financial Officer
AVY · Avery Dennison Corp
Effective
2024-11-14
Successor
Danny G. Allouche
Filed
November 15, 2024, 6:59 PM ET
On November 14, 2024, Gregory S. Lovins, Senior Vice President and Chief Financial Officer of Avery Dennison Corporation (the "Company"), began a medical leave of absence.
Departed

Jeffrey S. Berkes

President and Chief Operating Officer
Federal Realty OP LP
Effective
2024-12-31
Filed
November 15, 2024, 6:59 PM ET
On November 15, 2024, Federal Realty Investment Trust (the “Company”) reported that Jeffrey S. Berkes, the Company’s President and Chief Operating Officer, will depart from the Company effective as of December 31, 2024.
Departed

Thomas M. White

Chairman of the Board
STRL · STERLING INFRASTRUCTURE, INC.
Effective
2024-12-31
Filed
November 15, 2024, 6:59 PM ET
On November 14, 2024, Thomas M. White, the Chairman of the Board of Directors (the "Board") of Sterling Infrastructure, Inc. (the "Company"), notified the Company of his intention to retire from the Board effective December 31, 2024.
Departed

Matthew D’Ambrosio

Director
BTSG · BrightSpring Health Services, Inc.
Effective
2024-11-12
Filed
November 15, 2024, 6:59 PM ET
On November 12, 2024, Matthew D’Ambrosio resigned as a member of the board of directors (the “Board”) of BrightSpring Health Services, Inc. (the “Company”), the Compensation Committee of the Board, and the Quality, Compliance, and Governance Committee of the Board, effective as of November 12, 2024.
Departed

Wayne E. Hardesty

Director
PISMO COAST VILLAGE INC
Effective
2024-09-17
Successor
Kim Dougherty
Filed
November 15, 2024, 6:59 PM ET
the resignation of Wayne E. Hardesty at the Pismo Coast Village Board meeting held on September 17, 2024.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.